August 9, 2016

Anti-cocaine vaccine soon to be tested in humans

A vaccine has been developed by Weill Cornell Medicine and NewYork-Presbyterian, to blunt the effects of cocaine and potentially prevent it from reaching the brain. The vaccine, called dAd5GNE, has successfully completed pre-clinical studies and has now advanced to Phase 1 testing in humans. Investigators are now enrolling active cocaine […]